{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:15:08Z","timestamp":1791969308656,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T00:00:00Z","timestamp":1719100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFD1800500"],"award-info":[{"award-number":["2022YFD1800500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2020CXGC010801"],"award-info":[{"award-number":["2020CXGC010801"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2020CXGC010801-01-01"],"award-info":[{"award-number":["2020CXGC010801-01-01"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.vaccine.2024.06.020","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T08:05:24Z","timestamp":1718870724000},"page":"126052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Thoughts on the research of African swine fever live-attenuated vaccines"],"prefix":"10.1016","volume":"42","author":[{"given":"Xuefei","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqiang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naijun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0857-8080","authenticated-orcid":false,"given":"Yihong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 10","key":"10.1016\/j.vaccine.2024.06.020_b0005","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/0022-1317-79-10-2543","article-title":"African swine fever virus NL gene is not required for virus virulence","volume":"79","author":"Afonso","year":"1998","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2013.02.005","article-title":"BacMam immunization partially protects pigs against sublethal challenge with African swine fever virus","volume":"98","author":"Argilaguet","year":"2013","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0015","first-page":"2","article-title":"African swine fever. I antiserum production can","volume":"31","author":"Bannister","year":"1967","journal-title":"J Comp Med Vet Sci"},{"key":"10.1016\/j.vaccine.2024.06.020_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761753","article-title":"Safety of African swine fever vaccine candidate Lv17\/WB\/Rie1 in wild boar: overdose and repeated doses","volume":"12","author":"Barasona","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.06.020_b0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00705-002-0946-8","article-title":"Genotyping field strains of African swine fever virus by partial p72 gene characterisation","volume":"148","author":"Bastos","year":"2003","journal-title":"Arch Virol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2024.06.020_b0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.vetmic.2004.09.003","article-title":"Co-circulation of two genetically distinct viruses in an outbreak of African swine fever in mozambique: no evidence for individual co-infection","volume":"103","author":"Bastos","year":"2004","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.virusres.2012.10.026","article-title":"Pathogenesis of African swine fever in domestic pigs and European wild boar","volume":"173","author":"Blome","year":"2013","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2024.06.020_b0040","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1128\/JVI.72.4.2881-2889.1998","article-title":"Deletion of a CD2-like gene, 8-DR, from African swine fever virus affects viral infection in domestic swine","volume":"72","author":"Borca","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0045","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41598-020-57455-3","article-title":"Deletion of CD2-like gene from the genome of African swine fever virus strain Georgia does not attenuate virulence in swine","volume":"10","author":"Borca","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2024.06.020_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/v13050765","article-title":"ASFV-G-\u0394I177L as an effective oral nasal vaccine against the eurasia strain of africa swine fever","volume":"13","author":"Borca","year":"2021","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2024.06.020_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02017-19","article-title":"Development of a highly effective african swine fever virus vaccine by deletion of the I177L gene results in sterile immunity against the current epidemic eurasia strain","volume":"94","author":"Borca","year":"2020","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2024.06.020_b0060","doi-asserted-by":"crossref","first-page":"e1010931","DOI":"10.1371\/journal.ppat.1010931","article-title":"Cross-protection against African swine fever virus upon intranasal vaccination is associated with an adaptive-innate immune crosstalk","volume":"18","author":"Bosch-Cam\u00f3s","year":"2022","journal-title":"PLoS Pathog"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2024.06.020_b0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vetmic.2006.11.007","article-title":"Genetic characterisation of African swine fever viruses from outbreaks in southern Africa (1973\u20131999)","volume":"121","author":"Boshoff","year":"2007","journal-title":"Vet Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.06.020_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/v14122619","article-title":"African swine fever modified live vaccine candidates: transitioning from discovery to product development through harmonized standards and guidelines","volume":"14","author":"Brake","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2024.06.020_b0075","article-title":"High doses of inactivated african swine fever virus are safe, but do not confer protection against a virulent challenge","volume":"9","author":"Cadenas-Fern\u00e1ndez","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.vaccine.2024.06.020_b0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11427-020-1657-9","article-title":"A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs","volume":"63","author":"Chen","year":"2020","journal-title":"Sci China Life Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2024.06.020_b0090","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3201\/eid2404.172127","article-title":"Identification of wild boar-habitat epidemiologic cycle in African swine fever epizootic","volume":"24","author":"Chenais","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.020_b0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0368-1742(21)80031-4","article-title":"On a form of swine fever occurring in British East Africa (Kenya Colony)","volume":"34","author":"Eustace Montgomery","year":"1921","journal-title":"J Compar Pathol Therapeutics"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12985-020-01450-7","article-title":"The recombinant pseudorabies virus expressing African swine fever virus CD2v protein is safe and effective in mice","volume":"17","author":"Feng","year":"2020","journal-title":"Virol J"},{"issue":"2\u20134","key":"10.1016\/j.vaccine.2024.06.020_b0105","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.vetmic.2012.11.027","article-title":"Modulation of chemokine and chemokine receptor expression following infection of porcine macrophages with African swine fever virus","volume":"162","author":"Fishbourne","year":"2013","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1297-9716-44-87","article-title":"Increase in chemokines CXCL10 and CCL2 in blood from pigs infected with high compared to low virulence African swine fever virus isolates","volume":"44","author":"Fishbourne","year":"2013","journal-title":"Vet Res"},{"issue":"12","key":"10.1016\/j.vaccine.2024.06.020_b0115","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3201\/eid1712.110430","article-title":"Characterization of African swine fever virus caucasus isolate in European wild boars","volume":"17","author":"Gabriel","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2024.06.020_b0120","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/tbed.12431","article-title":"Experimental transmission of African swine fever (ASF) low virulent isolate NH\/P68 by surviving pigs","volume":"62","author":"Gallardo","year":"2015","journal-title":"Transbound Emerg Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.06.020_b0125","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/tbed.13132","article-title":"Attenuated and non-haemadsorbing (non-HAD) genotype II African swine fever virus (ASFV) isolated in Europe, Latvia 2017","volume":"66","author":"Gallardo","year":"2019","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2024.06.020_b0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fvets.2020.00215","article-title":"African swine fever virus: an emerging DNA arbovirus","volume":"7","author":"Gaudreault","year":"2020","journal-title":"Front Vet Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2024.06.020_b0135","article-title":"Subunit vaccine approaches for African swine fever virus","volume":"7","author":"Gaudreault","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.vaccine.2024.06.020_b0140","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00705-008-0196-5","article-title":"The low-virulent African swine fever virus (ASFV\/NH\/P68) induces enhanced expression and production of relevant regulatory cytokines (IFNalpha, TNFalpha and IL12p40) on porcine macrophages in comparison to the highly virulent ASFV\/L60","volume":"153","author":"Gil","year":"2008","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.06.020_b0145","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/JVI.73.3.2173-2180.1999","article-title":"African swine fever virus infection induces tumor necrosis factor alpha production: implications in pathogenesis","volume":"73","author":"G\u00f3mez del Moral","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.06.020_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2020.578474","article-title":"Genetic analysis of African swine fever virus from the 2018 outbreak in South-Eastern Burundi","volume":"7","author":"Hakizimana","year":"2020","journal-title":"Front Vet Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13567-018-0585-z","article-title":"Comparative proteomic analysis reveals different responses in porcine lymph nodes to virulent and attenuated homologous African swine fever virus strains","volume":"49","author":"Herrera-Uribe","year":"2018","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2024.06.020_b0160","first-page":"1","article-title":"African swine fever virus. Virol","volume":"9","author":"Hess","year":"1971","journal-title":"Monogr"},{"key":"10.1016\/j.vaccine.2024.06.020_b0165","first-page":"39","article-title":"African swine fever: a reassessment","volume":"25","author":"Hess","year":"1981","journal-title":"Adv Vet Sci Comp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2024.06.020_b0170","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/JVI.03250-14","article-title":"The progressive adaptation of a georgian isolate of African swine fever virus to vero cells leads to a gradual attenuation of virulence in swine corresponding to major modifications of the viral genome","volume":"89","author":"Krug","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.06.020_b0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13567-015-0275-z","article-title":"Live attenuated African swine fever viruses as ideal tools to dissect the mechanisms involved in viral pathogenesis and immune protection","volume":"46","author":"Lacasta","year":"2015","journal-title":"Vet Res"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2024.06.020_b0180","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1099\/0022-1317-82-3-513","article-title":"The non-haemadsorbing African swine fever virus isolate ASFV\/NH\/P68 provides a model for defining the protective anti-virus immune response","volume":"82","author":"Leit\u00e3o","year":"2001","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.06.020_b0185","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1128\/JVI.74.3.1275-1285.2000","article-title":"An African swine fever virus ERV1-ALR homologue, 9GL, affects virion maturation and viral growth in macrophages and viral virulence in swine","volume":"74","author":"Lewis","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0190","doi-asserted-by":"crossref","first-page":"e0150021","DOI":"10.1128\/JVI.01500-21","article-title":"A QP509L\/QP383R-deleted African swine fever virus is highly attenuated in swine but does not confer protection against parental virus challenge","volume":"96","author":"Li","year":"2022","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2024.06.020_b0195","article-title":"African swine fever virus: a review","volume":"12","author":"Li","year":"2022","journal-title":"Life (Basel)"},{"key":"10.1016\/j.vaccine.2024.06.020_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105024","article-title":"Research progress on live attenuated vaccine against African swine fever virus","volume":"158","author":"Liu","year":"2021","journal-title":"Microb Pathog"},{"issue":"9","key":"10.1016\/j.vaccine.2024.06.020_b0205","article-title":"Deletion mutants of the attenuated recombinant ASF Virus, BA71\u0394CD2","volume":"13","author":"Lopez","year":"2021","journal-title":"Show Decreased Vaccine Efficacy Viruses"},{"issue":"12","key":"10.1016\/j.vaccine.2024.06.020_b0210","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s00705-005-0602-1","article-title":"Molecular epidemiology of African swine fever in East Africa","volume":"150","author":"Lubisi","year":"2005","journal-title":"Arch Virol"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2024.06.020_b0215","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1099\/jgv.0.000024","article-title":"African swine fever virus CD2v and C-type lectin gene loci mediate serological specificity","volume":"96","author":"Malogolovkin","year":"2015","journal-title":"J Gen Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2024.06.020_b0220","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01058-17","article-title":"BA71\u0394CD2: a new recombinant live attenuated African swine fever virus with cross-protective capabilities","volume":"91","author":"Monteagudo","year":"2017","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.06.020_b0225","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.virol.2003.11.011","article-title":"Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection","volume":"319","author":"Neilan","year":"2004","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.vaccine.2024.06.020_b0230","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.76.7.3095-3104.2002","article-title":"Novel swine virulence determinant in the left variable region of the African swine fever virus genome","volume":"76","author":"Neilan","year":"2002","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2024.06.020_b0235","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1128\/JVI.00554-15","article-title":"African swine fever virus georgia isolate harboring deletions of MGF360 and MGF505 genes is attenuated in swine and confers protection against challenge with virulent parental virus","volume":"89","author":"O'Donnell","year":"2015","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2024.06.020_b0240","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1128\/JVI.00969-15","article-title":"African swine fever virus Georgia 2007 with a deletion of virulence-associated gene 9GL (B119L), when administered at low doses, leads to virus attenuation in swine and induces an effective protection against homologous challenge","volume":"89","author":"O'Donnell","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.06.020_b0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2016.05.014","article-title":"African swine fever virus Georgia isolate harboring deletions of 9GL and MGF360\/505 genes is highly attenuated in swine but does not confer protection against parental virus challenge","volume":"221","author":"O'Donnell","year":"2016","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0250","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01760-16","article-title":"Simultaneous deletion of the 9GL and UK genes from the African swine fever virus Georgia 2007 isolate offers increased safety and protection against homologous challenge","volume":"91","author":"O'Donnell","year":"2017","journal-title":"J Virol"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2024.06.020_b0255","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1099\/vir.0.81038-0","article-title":"In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus","volume":"86","author":"Oura","year":"2005","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.06.020_b0260","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2460\/ajvr.1985.46.02.314","article-title":"Diversity of African swine fever virus","volume":"46","author":"Pan","year":"1985","journal-title":"Am J Vet Res"},{"issue":"19","key":"10.1016\/j.vaccine.2024.06.020_b0265","article-title":"African swine fever: the state of the art in Italy","volume":"13","author":"Pavone","year":"2023","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.vaccine.2024.06.020_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.832264","article-title":"Vaccination with a gamma irradiation-inactivated African swine fever virus is safe but does not protect against a challenge","volume":"13","author":"Pikalo","year":"2022","journal-title":"Front Immunol"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2024.06.020_b0275","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1099\/vir.0.070508-0","article-title":"Related strains of African swine fever virus with different virulence: genome comparison and analysis","volume":"96","author":"Portugal","year":"2015","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2024.06.020_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/v11070599","article-title":"Differential effect of the deletion of African swine fever virus virulence-associated genes in the induction of attenuation of the highly virulent Georgia strain","volume":"11","author":"Ramirez-Medina","year":"2019","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.vaccine.2024.06.020_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/v14081834","article-title":"ASFV Gene A151R Is involved in the process of virulence in domestic swine","volume":"14","author":"Ramirez-Medina","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0290","doi-asserted-by":"crossref","first-page":"e0141921","DOI":"10.1128\/JVI.01419-21","article-title":"Deletion of E184L, a putative DIVA target from the pandemic strain of african swine fever virus, produces a reduction in virulence and protection against virulent challenge","volume":"96","author":"Ramirez-Medina","year":"2022","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.06.020_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.692448","article-title":"African swine fever in smallholder sardinian farms: last 10 years of network transmission reconstruction and analysis","volume":"8","author":"Rolesu","year":"2021","journal-title":"Front Vet Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/viro.1996.0193","article-title":"Functional and immunological properties of the baculovirus-expressed hemagglutinin of African swine fever virus","volume":"218","author":"Ruiz-Gonzalvo","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.06.020_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.11.021","article-title":"Different routes and doses influence protection in pigs immunised with the naturally attenuated African swine fever virus isolate OURT88\/3","volume":"138","author":"S\u00e1nchez-Cord\u00f3n","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2024.06.020_b0310","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virusres.2015.12.002","article-title":"Deletion of the thymidine kinase gene induces complete attenuation of the Georgia isolate of African swine fever virus","volume":"213","author":"Sanford","year":"2016","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2024.06.020_b0315","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9040274","article-title":"Protective properties of attenuated strains of African swine fever virus belonging to seroimmunotypes I-VIII","volume":"9","author":"Sereda","year":"2020","journal-title":"Pathogens"},{"issue":"11","key":"10.1016\/j.vaccine.2024.06.020_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11111311","article-title":"The presence of virus neutralizing antibodies is highly associated with protection against virulent challenge in domestic pigs immunized with ASFV live attenuated vaccine candidates","volume":"11","author":"Silva","year":"2022","journal-title":"Pathogens"},{"issue":"123","key":"10.1016\/j.vaccine.2024.06.020_b0325","first-page":"475","article-title":"Antibody response to inactivated preparations of African swine fever virus in pigs","volume":"28","author":"Stone","year":"1967","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.020_b0330","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1080\/22221751.2021.1999779","article-title":"Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infection","volume":"10","author":"Sun","year":"2021","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2024.06.020_b0335","article-title":"Generation and evaluation of an African swine fever virus mutant with deletion of the CD2v and UK genes","volume":"8","author":"Teklue","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"14","key":"10.1016\/j.vaccine.2024.06.020_b0340","doi-asserted-by":"crossref","first-page":"e0054522","DOI":"10.1128\/jvi.00545-22","article-title":"Deletion of the H108R gene reduces virulence of the pandemic eurasia strain of African swine fever virus with surviving animals being protected against virulent challenge","volume":"96","author":"Vuono","year":"2022","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.06.020_b0345","article-title":"Immune escape mechanism and vaccine research progress of African swine fever virus","volume":"10","author":"Wang","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"23","key":"10.1016\/j.vaccine.2024.06.020_b0350","doi-asserted-by":"crossref","first-page":"e0119921","DOI":"10.1128\/JVI.01199-21","article-title":"African swine fever virus bearing an I226R gene deletion elicits robust immunity in pigs to African swine fever","volume":"95","author":"Zhang","year":"2021","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2024.06.020_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/v14092021","article-title":"African swine fever vaccinology: the biological challenges from immunological perspectives","volume":"14","author":"Zhu","year":"2022","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2024.06.020_b0360","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1128\/JVI.75.7.3066-3076.2001","article-title":"African swine fever virus multigene family 360 and 530 genes are novel macrophage host range determinants","volume":"75","author":"Zsak","year":"2001","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.06.020_b0365","doi-asserted-by":"crossref","first-page":"8865","DOI":"10.1128\/jvi.70.12.8865-8871.1996","article-title":"An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene","volume":"70","author":"Zsak","year":"1996","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:20:31Z","timestamp":1777537231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24006935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":72,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0264410X24006935"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thoughts on the research of African swine fever live-attenuated vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126052"}}